IPC raises concern over five lifesaving drugs for causing adverse reaction

New Delhi: The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects. The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller. During a recently conducted analysis of adverse drug reactions (ADRs),…

Read More

Should cancer be a notifiable disease?

Department of Medical Oncology at Nizam’s Institute of Medical Sciences (NIMS), Hyderabad organised an awareness walk to promote cancer prevention making ‘World Cancer Day’ on Tuesday, February 4, 2025. | Photo Credit: RAMAKRISHNA G Time and again, there have been calls to designate cancer as a notifiable disease in India. While some argue that this…

Read More

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second quarter of the…

Read More

Cancer was fastest-growing ailment in 2024: Medi Assist report

Cancer was the fastest-growing ailment in India in 2024, while respiratory illnesses saw the highest increase in the average cost of treatment, a report released by health benefits administrator Medi Assist said on Thursday. Cancer incidence rates—the percentage of claims with respect to overall people insured—grew 10-12% year-on-year in 2024, according to the report. Incidences…

Read More
Back To Top